Distraction osteogenesis with transplantation of culture expanded bone marrow cells

Distraction osteogenesis with transplantation of culture expanded bone marrow cells - Distraction osteogenesis with transplantation of culture expanded bone marrow cells

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001251

Enrollment

Registered

2008-10-01

Start date

2002-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal dysplasia, Limb length discrepancy

Interventions

Transplantation of culture expanded bone marrow cells Control without cell therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who undergo distraction osteogenesis and agree with this treatment

Exclusion criteria

Exclusion criteria: Patients who are planned to lengthen less than 3cm.

Design outcomes

Primary

Measure	Time frame
Healing Index (days/cm)	—

Secondary

Measure	Time frame
Complications	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026